- Home
- ACM vs WST Comparison
ACM vs WST Comparison
Compare ACM & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACM
- WST
- Stock Information
- Founded
- ACM 1980
- WST 1923
- Country
- ACM United States
- WST United States
- Employees
- ACM N/A
- WST N/A
- Industry
- ACM Military/Government/Technical
- WST Medical/Dental Instruments
- Sector
- ACM Consumer Discretionary
- WST Health Care
- Exchange
- ACM Nasdaq
- WST Nasdaq
- Market Cap
- ACM 17.6B
- WST 20.1B
- IPO Year
- ACM 2007
- WST N/A
- Fundamental
- Price
- ACM $102.99
- WST $280.52
- Analyst Decision
- ACM Strong Buy
- WST Strong Buy
- Analyst Count
- ACM 11
- WST 9
- Target Price
- ACM $138.82
- WST $354.50
- AVG Volume (30 Days)
- ACM 1.3M
- WST 677.4K
- Earning Date
- ACM 11-18-2025
- WST 10-23-2025
- Dividend Yield
- ACM 1.19%
- WST 0.32%
- EPS Growth
- ACM 42.91
- WST 0.17
- EPS
- ACM 4.22
- WST 6.75
- Revenue
- ACM $16,139,622,000.00
- WST $3,017,900,000.00
- Revenue This Year
- ACM $7.02
- WST $6.97
- Revenue Next Year
- ACM $6.82
- WST $6.11
- P/E Ratio
- ACM $24.63
- WST $40.58
- Revenue Growth
- ACM 0.21
- WST 4.92
- 52 Week Low
- ACM $85.00
- WST $187.43
- 52 Week High
- ACM $135.52
- WST $348.90
- Technical
- Relative Strength Index (RSI)
- ACM 16.58
- WST 57.49
- Support Level
- ACM $102.80
- WST $253.32
- Resistance Level
- ACM $134.36
- WST $266.26
- Average True Range (ATR)
- ACM 4.44
- WST 8.57
- MACD
- ACM -3.48
- WST 0.05
- Stochastic Oscillator
- ACM 1.09
- WST 83.63
About ACM AECOM
Aecom is one of the largest global providers of design, engineering, construction, and management services. It serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $16.1 billion in sales in fiscal 2024.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.